|
July 30, 2010
|
| 08:36 EDT |  | GSK |
| theflyonthewall.com: | GlaxoSmithKline's FluLaval released by FDA | | GlaxoSmithKline announced that the FDA Center for Biologics Evaluation and Research has released the first lots of FluLaval, Influenza Virus Vaccine, allowing distribution in the U.S. to begin for the 2010-2011 flu season. GSK anticipates distribution of Fluarix, Influenza Virus Vaccine, to follow in the next several weeks. :theflyonthewall.com |
|
|
July 27, 2010
|
| 10:41 EDT |  | GSK |
| theflyonthewall.com: | Lazard Capital's biotech research team to hold a conference call | | Biotech Research Team discusses the FDA and The Agency for Healthcare Research and Quality's (AHRQ) ongoing safety review of stimulant medications used in children with ADHD (Attention Deficit/Hyperactivity Disorder). Drugs to be discussed could include Novartis' Focalin, Focalin XR, Ritalin, Ritalin-LA, Ritalin-SR, GlaxosmithKline's Dexedrine, Shire Pharmaceuticals' Adderall, Adderall XR, Vyvanse on the Analyst/Industry conference call to be held on August 2 at 11 am hosted by Lazard Capital. :theflyonthewall.com |
|
| 07:18 EDT |  | GSK |
| theflyonthewall.com: | GlaxoSmithKline to use new system to pay sales staff, WSJ reports | | Beginning in 2011, GlaxoSmithKline (GSK) will begin a new approach to evaluate and compensate its sales staff, including using customer feedback, reports the Wall Street Journal. Reference Link :theflyonthewall.com |
|
|
July 26, 2010
|
| 08:39 EDT |  | GSK |
|
| 08:26 EDT |  | GSK |
|
| 08:00 EDT | | GSK |
|
| 06:42 EDT | | GSK |
|
| 06:20 EDT | | GSK |
|
|
July 22, 2010
|
| 05:36 EDT | | GSK |
|
|
July 21, 2010
|
| 15:04 EDT | | GSK |
|
| 12:20 EDT | | GSK |
|
| 07:46 EDT |  | GSK |
| theflyonthewall.com: | U.S. stock futures rise on Apple results ahead of Bernanke testimony | | U.S. stock futures are rising modestly as investors focus more on an upbeat earnings report from Apple (AAPL) than on disappointing results from Yahoo (YHOO). U.S. stocks are on course for gains today as investors await testimony from Fed Chairman who will deliver his monetary policy report to the Senate Banking Committee at 2 pm ET. The Fed chief is expected to say the economy is growing slowly but it's unlikely to fall back into recession. Before that investors will digest a number of earnings reports from companies including Morgan Stanley (MS), Wells Fargo (WFC), Freeport McMoRan Copper & Gold (FCX), GlaxoSmithKline (GSK), eBay (EBAY) and Starbucks (SBUX). Dow futures are up 21 points to 10,199, the S&P's 500 index futures are up 3.8 points to 1,083.90, and the Nasdaq 100 index futures are up 10.8 points to 1,850.5. The Dow ended up 0.7% yesterday reversing intraday triple-digit losses. :theflyonthewall.com |
|
| 07:30 EDT |  | GSK |
| theflyonthewall.com: | GlaxoSmithKline: U.S. business performance will be effected by healthcare reform | | The company says that its U.S business performance in the short run will be impacted by reductions in pricing from healthcare reform. :theflyonthewall.com |
|
| 07:26 EDT | | GSK |
| theflyonthewall.com: | GlaxoSmithKline raises Q2 dividend 7% to 15p | | :theflyonthewall.com |
|
| 07:25 EDT | | GSK |
| theflyonthewall.com: | GlaxoSmithKline Q2 revenue impacted by generic competition to Valtrex in U.S. |
 Subscribe for More Information :theflyonthewall.com |
|
| 07:20 EDT | | GSK |
|
| 07:15 EDT | | GSK |
|
|
July 20, 2010
|
| 22:04 EDT | | GSK |
| theflyonthewall.com: | Glaxo, Baxter are "easy pickings" for savvy bargain hunters, Barrons.com says | | Recent events suggest that the regulatory headwinds facing Baxter International (BAX) and GlaxoSmithKline (GSK) are not as severe as many initially feared. With P/E multiples hovering near record lows, growing dividends and promising new products in development, Glaxo and Baxter could return 20% or better over the next 12 to 18 months. Reference Link :theflyonthewall.com |
|
| 12:13 EDT | | GSK |
| theflyonthewall.com: | As Swine flu pandemic abates, drug makers await next flu season | | Next week the World Health Organization reportedly may announce that the swine flu pandemic is over if it's determined that the worst has passed. The vaccines and medicines to fight it cost billions and it took over 18,000 lives. Roche Holding sold about $3.5B of Tamiflu in 2009 and GlaxoSmithKline (GSK) tallied nearly $3.8B as the overall total revenue for all drug companies is estimated at $10B-plus. While the rare pandemic may have been a onetime revenue bonanza a typical flu season can cost 500,000 lives. What's next is that a new flu season is coming and drug makers will benefit. :theflyonthewall.com |
|
| 08:14 EDT | | GSK |
| theflyonthewall.com: | Glaxo said to have paid $1B to resolve Paxil defect suits, Bloomberg reports | | :theflyonthewall.com |
|
| 08:09 EDT | | GSK |
|
|
July 19, 2010
|
| 08:01 EDT | | GSK |
|
| 07:52 EDT | | GSK |
|
